Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.35
-2.2%
$1.42
$0.90
$3.49
$68.76M-0.9743,629 shs25,642 shs
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$5.16
-2.1%
$5.89
$3.80
$10.77
$22.88M-0.9421,571 shs5,366 shs
CORBF
Global Cord Blood
$1.35
+90.1%
$1.01
$0.25
$2.00
$164.09M-0.52102,862 shs1,845 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$2.60
-5.5%
$2.40
$1.37
$9.13
$103.60M0.9995,571 shs70,551 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
-2.18%+5.08%-3.10%-14.33%-46.58%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
+1.78%+1.28%-10.88%-30.36%-34.93%
CORBF
Global Cord Blood
0.00%+90.14%+145.23%+23.85%-10.00%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-5.45%-6.47%-4.41%+17.12%-64.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.3274 of 5 stars
0.05.00.00.00.60.00.0
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.5126 of 5 stars
0.02.00.00.01.92.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.00
N/AN/AN/A
CORBF
Global Cord Blood
0.00
N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M50.96N/AN/A$0.48 per share2.80
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$52.60M0.43N/AN/A$51.05 per share0.10
CORBF
Global Cord Blood
$196.12M0.84$0.96 per share1.40N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$115K851.74N/AN/A$1.40 per share1.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.60N/AN/A-191.34%-30.95%-27.00%8/13/2025 (Estimated)
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$42.23MN/A0.00N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$32.90M-$0.85N/AN/AN/A-30,306.48%-49.78%-36.40%N/A

Latest CCM, SERA, CORBF, and ATPC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 million
5/15/2025Q1 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/14/2025Q1 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
24.68
24.64
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
1.67
0.46
0.45
CORBF
Global Cord Blood
N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
2.02
2.02

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
CORBF
Global Cord Blood
N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
CORBF
Global Cord Blood
0.50%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
13.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
9704.34 million2.32 millionNot Optionable
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12037.67 million32.59 millionOptionable

Recent News About These Companies

Sera Prognostics, Inc. (SERA) Q2 2025 Earnings Call Transcript
Sera Prognostics (SERA) Q2 Loss Down 4%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.34 -0.03 (-2.18%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$1.35 +0.01 (+0.37%)
As of 08/7/2025 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Concord Medical Services stock logo

Concord Medical Services NYSE:CCM

$5.16 -0.11 (-2.09%)
Closing price 08/7/2025 03:55 PM Eastern
Extended Trading
$5.39 +0.23 (+4.46%)
As of 08/7/2025 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Global Cord Blood NYSE:CORBF

$1.35 +0.64 (+90.14%)
As of 08/5/2025 02:11 PM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$2.60 -0.15 (-5.45%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$3.08 +0.48 (+18.27%)
As of 08/7/2025 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.